VACCINES
Make next year's flu shots, says FDA committee
Vaccine experts on an FDA advisory committee said Thursday the agency should instruct flu vaccine manufacturers to make next winter's shots using the strains recommended by the World Health Organization.
Vinay Prasad, the outgoing head of the FDA's Center for Biologics Evaluation and Research, previously suggested he would require flu vaccine manufacturers to conduct effectiveness trials before licensing updated shots — a demand experts insist isn't feasible, given the tight turnaround. But there was no discussion of that idea at the Vaccines and Related Biological Products Advisory Committee meeting.
In related news, the committee heard a report on how well flu shots appear to be working this winter. Though there was significant concern that the late emergence of a new strain of H3N2 would seriously undermine the effectiveness of this year's shot, the CDC reported (in its online MMWR journal) that the vaccines were moderately protective against hospitalization — for those people vaccinated. But a representative of the manufacturers who supply flu shots to the U.S. noted that number is steadily shrinking, with 40 million fewer doses supplied to the market in 2025-2026 than four years ago. — Helen Branswell
POLITICS
Americans credit Trump over Biden for trying to lower drug prices
The Trump and Biden administrations have both made lower drug prices a priority. But Trump is getting more credit for his efforts, according to a new poll by KFF.
TrumpRx is the centerpiece of the president's efforts to lower drug prices, and he's touted the site extensively at White House events. It's paid off: 41% of Americans say it is likely the Trump administration's policies will lower their prescription drug costs, though the responses broke unsurprisingly along party lines, with 79% of Republicans, and 11% of Democrats agreeing.
Only 31% of respondents were aware of Biden's law directing Medicare to negotiate lower prices, which also limits annual drug price increases, caps seniors' monthly spending on insulin, and caps individuals' annual out-of-pocket drug spending in Medicare Part D.
Read more from STAT's John Wilkerson, who has the full rundown of the poll and a fun quote from Mark Cuban about why Democrats don't get credit for their policies.
FIRST OPINION
How surrealism helps us make sense of and live with dementia
Molly Ferguson for STAT
Surrealism, a 20th century aesthetic and artistic philosophy, could be the solution to a vexing debate in dementia care, writes Jason Karlawish, a professor of medicine, medical ethics, health policy, and neurology at the University of Pennsylvania's Perelman School of Medicine. People living with dementia, particularly advanced-stage dementia, often struggle to distinguish between what is real and what is not. Surrealism rejects that binary, using various techniques and media such as collage, painting, and photography to instead disrupt and question our tightly-held conceptions of "the real."
Read more from Karlawish about how exquisite corpses and André Breton can help caregivers make sense of their patients' dementia.
No comments